A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer

Ghadjar, 2021, Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09/10 Randomized Phase 3 Trial, Eur Urol, 80, 306, 10.1016/j.eururo.2021.05.033 Carrie, 2019, Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial, Lancet Oncol, 20, 1740, 10.1016/S1470-2045(19)30486-3 Yokomizo, 2020, Salvage radiotherapy versus hormone therapy for prostate-specific antigen failure after radical prostatectomy: a randomised, multicentre, open-label, phase 3 trial (JCOG0401)(dagger), Eur Urol, 77, 689, 10.1016/j.eururo.2019.11.023 Parker, 2020, Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial, Lancet, 396, 1413, 10.1016/S0140-6736(20)31553-1 Sargos, 2020, Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial, Lancet Oncol, 21, 1341, 10.1016/S1470-2045(20)30454-X Cox, 1999, Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy, Am Soc Therap Radiol Oncol Consensus Panel. J Clin Oncol, 17, 1155 Beresford, 2010, A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence, Clin Oncol, 22, 46, 10.1016/j.clon.2009.10.015 Sanguineti, 2021, Response on DCE-MRI predicts outcome of salvage radiotherapy for local recurrence after radical prostatectomy, Tumori, 107, 55, 10.1177/0300891620908950 Faiella, 2021, A prospective study assessing the post-prostatectomy detection rate of a presumed local failure at mpMR with Either (64)CuCl2 or (64)CuPSMA PET/CT, Cancers, 13, 5564, 10.3390/cancers13215564 Connolly, 1996, Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins, Urology, 47, 225, 10.1016/S0090-4295(99)80421-X Masi, 2021, Comparison of rigid and deformable coregistration between mpMRI and CT images in radiotherapy of prostate bed cancer recurrence, Phys Medica, 92, 32, 10.1016/j.ejmp.2021.11.010 Sharma, 2018, Multiparametric magnetic resonance imaging is an independent predictor of salvage radiotherapy outcomes after radical prostatectomy, Eur Urol, 73, 879, 10.1016/j.eururo.2017.11.012 Thompson, 2013, Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline, J Urol, 190, 441, 10.1016/j.juro.2013.05.032 Cornford, 2021, EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer, Eur Urol, 79, 263, 10.1016/j.eururo.2020.09.046 Schaeffer, 2021, NCCN guidelines insights: prostate cancer, version 1.2021, J Natl Comprehensive Cancer Network: JNCCN, 19, 134, 10.6004/jnccn.2021.0008 Breen, 2021, The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer, Radiother Oncol, 161, 9, 10.1016/j.radonc.2021.05.015 Coppola, 2020, Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy, Radiol Med (Torino), 125, 683, 10.1007/s11547-020-01149-3 Panebianco, 2012, Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP), Eur J Radiol, 81, 700, 10.1016/j.ejrad.2011.01.095 Liauw, 2013, Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging, Int J Radiat Oncol Biol Phys, 85, 378, 10.1016/j.ijrobp.2012.05.015 Emmett, 2017, Treatment outcomes from (68)Ga-PSMA PET/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET, J Nucl Med, 58, 1972, 10.2967/jnumed.117.196683 King, 2016, The dose-response of salvage radiotherapy following radical prostatectomy: a systematic review and meta-analysis, Radiother Oncol, 121, 199, 10.1016/j.radonc.2016.10.026 Swanson, 2007, Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794, J Clin Oncol, 25, 2225, 10.1200/JCO.2006.09.6495 Roach, 2006, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference, Int J Radiat Oncol Biol Phys, 65, 965, 10.1016/j.ijrobp.2006.04.029 Rischke, 2012, Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil, Radiat Oncol, 7, 10.1186/1748-717X-7-185 Pilepich, 1986, Prognostic significance of the pattern of tumor regression following definitive radiotherapy for carcinoma of the prostate, Am J Clin Oncol, 9, 494, 10.1097/00000421-198612000-00006 Pasquier, 2018, Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer, Sci Rep, 8, 10.1038/s41598-018-28817-9 Song, 2010, Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T, AJR Am J Roentgenol, 194, W477, 10.2214/AJR.09.3557 Berman, 2016, DCE MRI of prostate cancer, Abdominal Radiol, 41, 844, 10.1007/s00261-015-0589-3 Schwartz, 2016, RECIST 1.1-Update and clarification: From the RECIST committee, Eur J Cancer, 62, 132, 10.1016/j.ejca.2016.03.081 Casciani, 2008, Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy, AJR Am J Roentgenol, 190, 1187, 10.2214/AJR.07.3032 Huang, 2018, Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients, J Magn Resonance Imaging: JMRI, 47, 191, 10.1002/jmri.25758 Spratt, 2016, Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases, Spine J, 16, 291, 10.1016/j.spinee.2015.08.041 Taunk, 2018, Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery, Neuro-oncology, 20, 567, 10.1093/neuonc/nox159 George, 2001, Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer, Br J Surg, 88, 1628, 10.1046/j.0007-1323.2001.01947.x Taverna, 2010, Microvessel density estimate: friend or foe in the light of prostate vascular system complexity?, World J Urol, 28, 405, 10.1007/s00345-010-0505-y